PPARGC1A and acute kidney injury: In restoring fatty acid oxidation, application of PGC1α agonist ZLN-005 or AMPK activator could significantly enhance FAO and inhibit the transition from AKI to CKD, thereby preventing the transition from AKI to CKD (Xu et al., 2023).